Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats

This publication has 25 references indexed in Scilit:

• Droloxifene inhibits cortical bone turnover associated with estrogen deficiency in rats
  Bone, 1995
• Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: A dual-energy X-ray absorptiometric and histomorphometric study
  Journal of Bone and Mineral Research, 1995
• Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats
  Endocrinology, 1995
• Estrogen Replacement Therapy and Fractures in Older Women
  Annals of Internal Medicine, 1995
• The effects of raloxifene on tibia histomorphometry in ovariectomized rats
  Endocrinology, 1994
• Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
  Journal of Clinical Investigation, 1994
• Bone loss in the elderly
  Osteoporosis International, 1994
• On the rat model of human osteopenias and osteoporoses
  Bone and Mineral, 1992
• The ovariectomized rat model of postmenopausal bone loss
  Bone and Mineral, 1991
• Pharmacologic and Biologic Properties of Droloxifene, A New Antiestrogen
  American Journal of Clinical Oncology, 1991